An interventional study of Cranberry juice and Placebo juice in Stress Response, Mental Stress and Multitasking Behavior and Multitasking Ability, sponsored by University of Florida. Recruiting at 1 site in United States. Open to participants aged 30 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-30.
Sponsored by University of Florida · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 290 studies in Stress, Psychological with a site in United States — 31 open to participants now, 46 under way, 1 of them phase 3. Stress, Psychological · United States.
Among the 290 studies in Stress, Psychological with a site in United States, this one is the 130th largest by planned enrollment of the 262 interventional ones that give a count, is one of 14 that started in 2026, is one of 240 with no phase, reaches primary completion later than 36 of the 45 other live ones, and was the 280th registered.
854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.
Browse Stress, Psychological studies →31 of the 290 studies in Stress, Psychological with a site in United States are open now. Recruiting first, the newest first:
Rachel Yehuda · Sites in United States
Ages 18+
University of Pennsylvania · Sites in United States
Ages 21–60 · Healthy volunteers
University of Arizona · Sites in United States
Ages 65+ · Healthy volunteers
Efforia, Inc · Sites in United States
Ages 18+ · Healthy volunteers
SF Research Institute, Inc. · Sites in United States
Ages 18–45 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 74 Stress, Psychological studies recruiting now, 34 (46%) set no upper age limit and 36 (49%) stop at 75 or younger; 13 take children under 18; 49 take healthy volunteers.
This study: 30 Years to 55 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
290 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 11 · Phase 3 3 · Phase 4 3
First in 1997; this study’s year is marked. 14 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 84 is close to the median of 84 across 698 interventional studies indexed under Stress, Psychological.
Median enrollment 84 across the 262 interventional studies, 138 across the 28 observational. Of the 226 that completed or were terminated, 60 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 290 have an industry lead sponsor. The 10 most frequent:
University of Florida is the lead sponsor of 1,290 studies on the registry; 202 are open to participants now.
Of its 181 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.
University of Florida has 3 studies filed under Stress, Psychological — fewer than ten, so there is no comparison to draw.
19 of the studies in Stress, Psychological with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05552053Phase 3Cedars-Sinai Medical CenterResources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women | 2026-12-31 |
| NCT07718646Oklahoma State UniversityMobile Health Coping Intervention for Mothers Experiencing Food Insecurity | 2026-11 |
| NCT06989593Sarah SchlegelBreaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions | 2026-11 |
| NCT04317482University of ArkansasThe Human Stress Response in a Simulated ED Setting | 2026-12 |
| NCT07029165University of Massachusetts, BostonKidney Blood Flow During Exercise in Older African American Adults | 2026-12 |
Add all 19 to your calendar (.ics) → With an account.
Among the 290 studies in Stress, Psychological with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized, double-blind, placebo-controlled clinical trial evaluates whether 70 days of daily cranberry juice consumption improves cognitive performance and motor accuracy and reduces psychological and physiological stress responses during a motor-cognitive dual-task multitasking challenge in healthy adults aged 30-55 (Aim 1). It is hypothesized that chronic cranberry juice intake will enhance dual-task performance and attenuate stress reactivity (Hypothesis 1). It is further hypothesized that cranberry juice will mitigate multitasking-related fatigue, mood fluctuations, and cognitive impairment, accompanied by favorable changes in circulating stress biomarkers and stress-regulatory neurochemical pathways (Aim 2/Hypothesis 2). Finally, the study incorporates gut analysis to determine whether cranberry juice induces beneficial shifts in the gut microbiota and microbial metabolites (e.g., SCFAs) and whether these changes are associated with improved cognitive and stress-related outcomes, consistent with a microbiome-gut-brain axis mechanism (Aim 3/Hypothesis 3).
Recruitment and Screening
Individuals who express interest will complete an initial study interest form. If preliminarily qualified, individuals will proceed to a screening process conducted via Qualtrics. Study staff will review responses to confirm eligibility and identify exclusions based on predefined criteria.
Study Design, Visits, and Timeline
This randomized, double-blind, placebo-controlled, parallel-design trial spans 13 weeks and includes three in-person visits: the consent visit (V1), the baseline visit (V2), and the final visit (V3).
Consent Visit (V1)
At V1, participants complete the informed consent process and undergo eligibility checks. These include measurement of height and weight to confirm BMI eligibility, pregnancy testing for female participants to ensure non-pregnant status, and a brief multitasking task capability check to confirm participants can comfortably perform the protocol tasks. Study staff will answer any questions, and V2 and V3 will be scheduled. Upon providing consent, participants enter the run-in phase.
Run-In Phase (Pre-Baseline)
Following V1, participants begin the run-in phase, adhering to the study's dietary restrictions. This includes avoiding cranberry products and specific polyphenol- or supplement-rich foods, as well as limiting caffeine and alcohol near visit days.
Baseline Visit (V2) and Final Visit (V3) Procedures
V2 (baseline) and V3 (final) follow the same structure, with the key difference being the assigned beverage at breakfast during V3.
Pre-Visit Requirements and Intake
Participants arrive after a 10-hour overnight fast. Upon arrival, participants submit a self-collected fecal sample for gut microbiome analysis. Compliance with dietary restrictions is confirmed, after which a phlebotomist draws a fasting blood sample (20 mL). Height and weight are measured.
Core Assessments (V2 and V3)
Multitasking (Dual-Task) Challenge and Stress Reactivity Participants perform a dual-task multitasking paradigm with continuous physiological monitoring. The cognitive task involves counting backward aloud from a random number between 800 and 999, subtracting by 3, 7, and 17 across three series. Each series lasts 4 minutes, with 90-second breaks in between, totaling 15 minutes. Scoring is based on the total correct/incorrect subtractions; if errors occur, participants continue from the new number. The motor task involves clicking rapidly shrinking dots on a screen, scored for target efficiency and accuracy. The multitasking session is video-recorded. Mood and stress are assessed using the State-Trait Anxiety Inventory (STAI-State) and Visual Analog Mood Scales (VAMS) immediately before and after the task. Saliva samples are collected immediately before, immediately after, and 60 minutes after the task to measure cortisol and alpha-amylase.
Standardized Meal (V2 vs. V3)
At V2, participants are served a standardized meal with water. At V3 (Day 70), the standardized meal remains the same, but water is replaced with 8 oz of the assigned beverage (either cranberry juice or placebo).
Cognitive Testing
Following the multitasking challenge and standardized meal, participants complete NIH Toolbox cognition and memory assessments.
Questionnaires and Symptom Monitoring
Participants complete measures assessing mental fatigue, perceived stress, and trait anxiety via Qualtrics.
Post-Visit and Follow-Up
After V2, participants leave with assigned beverages (8 oz per bottle; two bottles per day). V3, the final visit, mirrors V2, except the standardized meal includes 8 oz of the assigned beverage and an additional compliance questionnaire is administered. Participation ends after all final assessments are completed at V3.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cranberry juice will be provided by Ocean Spray Company.
Other: Cranberry juice
Placebo juice will be provided from Ocean Spray Company to match the appearance, taste, and calories of the cranberry beverage; it contains no active cranberry components.
Other: Placebo juice
Participants will consume the cranberry juice beverage by mouth each day for 70 days following a run-in period.
Participants will consume the placebo cranberry juice beverage by mouth each day for 70 days following a run-in period.
Cognitive task performance (serial subtraction accuracy)
Total number of correct subtractions during the multitasking cognitive task Measure Description: Counting backward aloud from a random number between 800-999 by 3, 7, and 17; performance scored as total correct subtractions across the task.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Cognitive task performance (serial subtraction errors)
Outcome Measure: Total number of incorrect subtractions during the multitasking cognitive task Measure Description: Same serial subtraction task; performance scored as total incorrect subtractions.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Mood
Change from baseline to end of intervention in mood assessed using the Visual Analog Mood Scale (VAMS). The VAMS is a self-report visual analog measure of current mood states collected during study visits per protocol.
Time frame: Baseline (Visit 2; pre- and post-multitasking task) and Final (Visit 3, Day 70; pre- and post-multitasking task). Through study completion (average of 2 years).
State anxiety
Change from baseline to end of intervention in state anxiety assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-State). The STAI-State is a self-report measure assessing state anxiety in response to multitasking stress collected during study visits per protocol.
Time frame: Baseline (Visit 2; pre- and post-multitasking task) and Final (Visit 3, Day 70; pre- and post-multitasking task). Through study completion (average of 2 years).
Mental fatigue
Change from baseline to end of intervention in mental fatigue assessed using the Mental Fatigue Scale (MFS). The MFS is a self-reported questionnaire evaluating perceived mental fatigue and related cognitive symptoms. Scores will be collected during study visits and analyzed per protocol to assess changes following cranberry juice intervention.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Sleep quality
Change from baseline to end of intervention in sleep quality assessed using the Leeds Sleep Evaluation Questionnaire (LSEQ). The LSEQ is a self-report questionnaire evaluating subjective sleep quality and related dimensions of sleep and awakening, collected during study visits per protocol.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Trait anxiety
Change from baseline to end of intervention in trait anxiety assessed using the State-Trait Anxiety Inventory - Trait Subscale (STAI-Trait). The STAI-Trait is a self-report measure of trait anxiety.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Food frequnecy questionnaire
Dietary intake patterns assessed using a Food Frequency Questionnaire (FFQ). The FFQ is a self-report measure used to evaluate habitual dietary intake and food consumption frequency during the run-in phase and throughout the intervention period per protocol.
Time frame: Run-in (pre-intervention), Baseline (Visit 2), Mid-Intervention, and Day 70 (Visit 3). Through study completion (average of 2 years).
Picture vocabulary test
NIH Toolbox Picture Vocabulary Test: to assess participants' ability to understand and identify the meaning of words by matching them to corresponding images.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Flanker inhibitory control and attention test
NIH Toolbox Flanker Inhibitory Control and Attention Test: to assess participants' cognitive control and attentional processes, specifically their ability to inhibit irrelevant information and focus on the relevant stimuli.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
List sorting working memory test
NIH Toolbox List Sorting Working Memory Test: to assess participants' working memory abilities.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Dimensional changes card sort test
NIH Toolbox Dimensional Changes Card Sort Test: to assess the cognitive flexibility of participants.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Pattern comparison processing speed test
NIH Toolbox Pattern Comparison Processing Speed Test: to assess the cognitive processing speed of participants.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Picture sequence memory test
NIH Toolbox Picture Sequence Memory Test: to assess participants' episodic memory.
Time frame: Time Frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Auditory verbal learning test
Auditory Verbal Learning Test: to assess participants' attention, memory, and learning ability in the auditory-verbal domain.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Picture sequence memory test
NIH Toolbox Picture Sequence Memory Test: to assess participants' episodic memory.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Heart rate
Heart rate (bpm) will be measured during multitasking.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Interbeat interval (IBI)
Interbeat interval (ms) will be measured during multitasking.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Galvanic skin response (GSR)
Galvanic skin response (μS) will be measured during multitasking.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Salivary alpha-amylase activity
Salivary alpha-amylase activity will be assessed using ELISA kit.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Salivary cortisol level
Salivary cortisol level will be measured by an enzyme immunoassay with the Cortisol Elisa Assay Kit.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Gut microbiome composition and diversity
Change from baseline to end of intervention in gut microbiome composition and diversity assessed from stool samples.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Short-chain fatty acids (SCFAs)
Change from baseline to end of intervention in fecal concentrations of acetic acid, propionic acid, and butyric acid assessed from stool samples.
Time frame: Baseline (Visit 2) and Final (Visit 3, Day 70). Through study completion (average of 2 years).
Start is estimated for Aug 2026; primary completion for May 2028, 21 months later.
Of 462 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 21 months is above that.
Counting every sponsor, half of 475 studies reached it within 13 months; a quarter within 5 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.